Posted in Industry News, Mobile News, News
A research team has discovered a new pharmaceutical on Easter Island which could be used to reverse the effects of aging, the Telegraph reports.
A chemical discovered in the soil of the island has been used to create Rapamycin which, when tested on children suffering from Hutchinson-Gilford Progeria Syndrome (HGPS), a disease which prematurely ages children, helped clear their cells of defects.
Researchers are already looking into the possibility of providing the drug to a wider market, after similarities between normal aging and HGPS were discovered. Dimitri Krainc, an author of the study into Rapamycin, believes a small dose of the drug can “extend the health and life span of our cells and organs”.
Looking for a job in science? Start by clicking here now
Posted in General, News
As reported by Reuters, the government will be looking to implement systems to help speed up clinical research in order to reduce red tape, thus making healthcare innovations more quickly available to patients.
The Academy of Medical Sciences (AMS) has put forward plans to create a new Health Research Agency which would act as a single portal for approvals needed in clinical research.
Michael Rawlins of the AMS stated, “The regulatory and governance environments for doing health research in the UK have been utterly stifling. Over the last 10 years there have been more and more regulatory and governance measures put in place … and the cumulative effect has been devastating. We cannot go on like this.”
The plans have been welcomed by a number of pharmaceutical industry groups as well as Health Minister, Andrew Lansley.
Are you looking for a new position in the UK pharmaceutical industry? Click here to search our current pharmaceutical and clinical research jobs online now.
Posted in General, News
Science company, Thermo Fisher Scientific has reported strong second quarter growth in 2010. This is due to the success of its investment and new product initiatives.
Thermo Fisher Scientific’s laboratory products and analytical technologies have benefit from the growth, whilst its molecular and cellular biology activities have been boosted by the acquisition of Fermentas.
The science company are looking to support their future expansion with new innovations in life sciences, clinical research and specialist diagnostics.
Marc Casper, president and chief executive officer of Thermo Fisher Scientific, said: “We successfully leveraged our top-line performance to achieve solid operating margin expansion and double-digit EPS growth.”
Are you looking for a new position in the scientific industry? Click here to search our current science jobs online now.